Semin Thromb Hemost 2010; 36(2): 157-162
DOI: 10.1055/s-0030-1251499
© Thieme Medical Publishers

CD36 and Macrophage Scavenger Receptor A Modulate Foam Cell Formation via Inhibition of Lipid-Laden Platelet Phagocytosis

Peter Seizer1 , Susanne Schiemann1 , Tobias Merz3 , Karin Daub1 , Boris Bigalke1 , Konstantinos Stellos1 , Iris Müller1 , Christina Stöckle2 , Karin Müller1 , Meinrad Gawaz1 , Andreas E. May1
  • 1Medizinische Klinik III, Eberhard Karls Universität Tübingen, Germany
  • 2Hertie Institute for Clinical Brain Research, Department of General Neurology, Tübingen, Germany
  • 3Institut für Angewandte Forschung, Reutlingen University, Reutlingen, Germany
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
22. April 2010 (online)

Preview

ABSTRACT

CD34+ progenitor cells are a promising source of regeneration in atherosclerosis or ischemic heart disease. However, as recently published, CD34+ progenitor cells have the potential to differentiate not only into endothelial cells but also into foam cells upon interaction with platelets. The mechanism of platelet-induced differentiation of progenitor cells into foam cells is as yet unclear. In the present study we investigated the role of scavenger receptor (SR)-A and CD36 in platelet-induced foam cell formation. Human CD34+ progenitor cells were freshly derived from human umbilical veins and were co-incubated with platelets (2 × 108/mL) up to 14 days resulting in large lipid-laden foam cells. Developing macrophages expressed SR-A, CD36, and Lox-1 as measured by fluorescent-activated cell sorting analysis. The presence of a blocking anti-CD36 or anti-SR-A antibody nearly abrogated foam cell formation, whereas anti-Lox-1 did not affect foam cell formation. Consistently blocking either anti-CD36 or anti-SR-A antibody significantly reduced the phagocytosis of lipid-laden platelets by macrophages. We conclude that CD36 and SR-A play an important role in platelet-induced foam cell formation from CD34+ progenitor cells and thus represent a promising target to inhibit platelet-induced foam cell formation.

REFERENCES

Peter SeizerM.D. 

Medizinische Klinik III, Universitätsklinikum Tübingen

Otfried-Müller Str.10, 72076 Tübingen, Germany

eMail: peter.seizer@med.uni-tuebingen.de